Breast cancer: a review for the general surgeon
CB Matsen, LA Neumayer - JAMA surgery, 2013 - jamanetwork.com
Breast cancer care is complex and requires a multidisciplinary approach. In this study, we
provide an overview of current practices for the diagnosis and treatment of breast cancer for …
provide an overview of current practices for the diagnosis and treatment of breast cancer for …
Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy
L Neal, NP Sandhu, TJ Hieken, KN Glazebrook… - Mayo Clinic …, 2014 - Elsevier
Imaging abnormalities detected by mammographic screening often lead to diagnostic
evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy …
evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy …
Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study
LC Hartmann, DC Radisky, MH Frost, RJ Santen… - Cancer Prevention …, 2014 - AACR
Atypical hyperplasia is a high-risk premalignant lesion of the breast, but its biology is poorly
understood. Many believe that atypical ductal hyperplasia (ADH) is a direct precursor for low …
understood. Many believe that atypical ductal hyperplasia (ADH) is a direct precursor for low …
[图书][B] Basics of oncology
FO Stephens, KR Aigner, TG Allen-Mersh - 2009 - Springer
In Western societies and other developed countries, cancer is the leading cause of death,
after cardiovascular disease. It is therefore a major component of medical undergraduate …
after cardiovascular disease. It is therefore a major component of medical undergraduate …
Serological thymidine kinase 1 is a biomarker for early detection of tumours—a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot …
ZH Chen, SQ Huang, Y Wang, AZ Yang, J Wen, XH Xu… - Sensors, 2011 - mdpi.com
Serological thymidine kinase 1 (STK1) is a reliable proliferation marker for prognosis,
monitoring tumour therapy, and relapse. Here we investigated the use of STK1 in health …
monitoring tumour therapy, and relapse. Here we investigated the use of STK1 in health …
[HTML][HTML] Lobular neoplasia: morphology, biological potential and management in core biopsies
FP O'malley - Modern pathology, 2010 - Elsevier
Lobular neoplasia has been traditionally recognized as a marker of increased risk for
subsequent breast carcinoma development; however, molecular studies suggest that it also …
subsequent breast carcinoma development; however, molecular studies suggest that it also …
Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation
KA Atkins, MA Cohen, B Nicholson, S Rao - Radiology, 2013 - pubs.rsna.org
Purpose To assess the utility of precise radiologic and pathologic correlation for establishing
imaging-histologic concordance or discordance as a method to limit the number of patients …
imaging-histologic concordance or discordance as a method to limit the number of patients …
Epidemiologic risk factors for in situ and invasive breast cancers among postmenopausal women in the National Institutes of Health-AARP Diet and Health Study
M Mullooly, ZG Khodr, CM Dallal… - American journal of …, 2017 - academic.oup.com
Comparing risk factor associations between invasive breast cancers and possible
precursors may further our understanding of factors related to initiation versus progression …
precursors may further our understanding of factors related to initiation versus progression …
Clonal relationships between lobular carcinoma in situ and other breast malignancies
Background Recent evidence suggests that lobular carcinoma in situ (LCIS) can be a clonal
precursor of invasive breast cancers of both the ductal and lobular phenotypes. We sought …
precursor of invasive breast cancers of both the ductal and lobular phenotypes. We sought …
[PDF][PDF] Recommendations for women with lobular carcinoma in situ (LCIS)
BA Oppong, TA King - Oncology-Melville, 2011 - researchgate.net
Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …